Avalyn Pharma Inc. Common Stock (AVLN) vs Innovage Holding Corp. (INNV)

A side-by-side comparison of Avalyn Pharma Inc. Common Stock and Innovage Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Avalyn Pharma Inc. Common Stock logo
AVLN
Avalyn Pharma Inc. Common Stock
$1.13B
$25.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Innovage Holding Corp. logo
INNV
Innovage Holding Corp.
$1.22B
$9.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AVLN vs INNV

growth of $100 · dividends reinvested · last 1y
AVLN -8.3% (-8.3%/yr)INNV +11.5% (+11.5%/yr)INNV compounded faster over this window
100120140Start $100$92$112
AVLN INNV

AVLN vs INNV: by the numbers

  • •INNV is the larger company ($1.22B vs $1.13B market cap).
  • •Both run net losses; AVLN's is the smaller (0.00% vs -0.26% net margin).

Metrics side by side

Valuation

MetricAVLNINNV
Forward P/EN/A20.44
P/S ratioN/A1.23
P/B ratio2.835.19
EV / EBITDAN/A14.35
FCF yieldN/A4.13%

Profitability

MetricAVLNINNV
Gross margin0.00%21.39%
Operating margin0.00%6.39%
Net margin0.00%-0.26%
ROEN/A-1.08%
ROIC-67.73%9.48%

Growth (annualized)

MetricAVLNINNV
Revenue CAGR (5Y)N/A9.19%
Total return CAGR (5Y)N/A5.55%

Go deeper

Full AVLN analysisFull INNV analysisInteractive comparison tool

Dig into the metrics

Avalyn Pharma Inc. Common Stock ROEInnovage ROEAvalyn Pharma Inc. Common Stock operating marginInnovage operating marginAvalyn Pharma Inc. Common Stock revenue growthInnovage revenue growthAvalyn Pharma Inc. Common Stock free cash flowInnovage free cash flow

Avalyn Pharma Inc. Common Stock & Innovage appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.